Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sorrento Therapeutics Inc (NASDAQ:SRNE)

2.05
Delayed Data
As of Jun 27
 -0.05 / -2.38%
Today’s Change
1.50
Today|||52-Week Range
8.35
-58.16%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$158.1M

Company Description

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.

Contact Information

Sorrento Therapeutics, Inc.
4955 Directors Place
San Diego California 92121
P:(858) 203-4100
Investor Relations:

Employees

Shareholders

Mutual fund holders4.64%
Individual stakeholders32.35%
Other institutional13.45%

Top Executives

Henry H. JiPresident, Chief Executive Officer & Director
Jeffrey SuChief Operating Officer & Executive Vice President
Kevin M. HerdeChief Financial Officer & Executive Vice President
Jerome B. ZeldisChief Medical Officer
George K. NgChief Administrative Officer & Executive VP